HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report.

AbstractRATIONALE:
Autosomal dominant hypocalcaemia type 1 (ADH1) is a genetic disease characterized by benign hypocalcemia, inappropriately low parathyroid hormone levels and mostly hypercalciuria. It is caused by the activating mutations of the calcium-sensing receptor gene (CASR), which produces a left-shift in the set point for extracellular calcium.
PATIENT CONCERNS:
A 50-year-old man presenting with muscle spasms was admitted into the hospital. He has a positive familial history for hypocalcemia. Auxiliary examinations demonstrated hypocalcemia, hyperphosphatemia, normal parathyroid hormone level and nephrolithiasis. A missense heterozygous variant in CASR, c 613C > T (p. Arg205Cys) which has been reported in a familial hypocalciuric hypercalcemia type 1 patient was found in the patient's genotype. It is the first time that this variant is found associating with ADH1. The variant is predicted vicious by softwares and cosegregates with ADH1 in this pedigree. CASR Arg205Cys was deduced to be the genetic cause of ADH1 in the family.
DIAGNOSIS:
The patient was diagnosed with ADH1 clinically and genetically.
INTERVENTIONS:
Oral calcitriol, calcium and hydrochlorothiazide were prescribed to the patient.
OUTCOMES:
After the treatments for 1 week, the patient's symptom was improved and the re-examination revealed serum calcium in the normal range. A 3-month follow-up showed his symptom was mostly relieved.
LESSONS:
The variant of CASR Arg205Cys, responsible for ADH1 in this family, broadened the genetic spectrum of ADH1. Further and more studies are required to evaluate the correlation between genotype and phenotype in ADH1 patients.
AuthorsYubing Ji, Chunyang Kang, Jiajun Chen, Lei Zhang
JournalMedicine (Medicine (Baltimore)) Vol. 100 Issue 25 Pg. e26443 (Jun 25 2021) ISSN: 1536-5964 [Electronic] United States
PMID34160437 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Chemical References
  • CASR protein, human
  • Receptors, Calcium-Sensing
  • Hydrochlorothiazide
  • Calcitriol
  • Calcium
Topics
  • Calcitriol (administration & dosage)
  • Calcium (administration & dosage, blood)
  • DNA Mutational Analysis
  • Drug Therapy, Combination (methods)
  • Female
  • Genetic Testing
  • Heterozygote
  • Humans
  • Hydrochlorothiazide (administration & dosage)
  • Hypercalciuria (blood, diagnosis, genetics)
  • Hypocalcemia (blood, diagnosis, genetics)
  • Hypoparathyroidism (blood, congenital, diagnosis, genetics)
  • Male
  • Medical History Taking
  • Middle Aged
  • Mutation, Missense
  • Pedigree
  • Receptors, Calcium-Sensing (genetics)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: